Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry. [electronic resource]
Producer: 20180709Description: 256 p. digitalISSN:- 1478-6362
- Adolescent
- Age of Onset
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antirheumatic Agents -- adverse effects
- Arthritis, Juvenile -- drug therapy
- Biological Products -- therapeutic use
- Child
- Child, Preschool
- Etanercept -- adverse effects
- Female
- Germany
- Humans
- Infections -- chemically induced
- Interleukin 1 Receptor Antagonist Protein -- adverse effects
- Male
- Registries -- statistics & numerical data
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.